This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Landles, C. Articles by Parker, M. G. Search for Related Content PubMed PubMed Citation Articles by Landles, C. Articles by Parker, M. G.

The Thyroid Hormone Receptor-Associated Protein TRAP220 Is Required at Distinct Embryonic Stages in Placental, Cardiac, and Hepatic Development

Institute of Reproductive and Developmental Biology (C.L., J.H.S., M.G.P.) and Department of Histopathology (B.S.-D., E.-N.L.), Imperial College, London W12 ONN, United Kingdom; and Cancer Research UK (S.C., I.R.), Clare Hall Laboratories, South Mimms, Potters Bar, Hertfordshire EN6 3LD, United Kingdom

Address all correspondence and requests for reprints to: Malcolm G. Parker, Institute of Reproductive and Developmental Biology, Imperial College, Faculty of Medicine, Du Cane Road, London W12 ONN, United Kingdom. E-mail: m.parker{at}imperial.ac.uk.

Recent work indicates that thyroid hormone receptor-associated protein 220 (TRAP220), a subunit of the multiprotein TRAP coactivator complex, is essential for embryonic survival. We have generated TRAP220 conditional null mice that are hypomorphic and express the gene at reduced levels. In contrast to TRAP220 null mice, which die at embryonic d 11.5 (E11.5), hypomorphic mice survive until E13.5. The reduced expression in hypomorphs results in hepatic necrosis, defects in hematopoiesis, and hypoplasia of the ventricular myocardium, similar to that observed in TRAP220 null embryos at an earlier stage. The embryonic lethality of null embryos at E11.5 is due to placental insufficiency. Tetraploid aggregation assays partially rescues embryonic development until E13.5, when embryonic loss occurs due to hepatic necrosis coupled with poor myocardial development as observed in hypomorphs. These findings demonstrate that, for normal placental function, there is an absolute requirement for TRAP220 in extraembryonic tissues at E11.5, with an additional requirement in embryonic tissues for hepatic and cardiovascular development thereafter.

NURSA Molecule Pages Link:

Coregulators:   TRAP220

This article has been cited by other articles:

				S. Ray, D. Dutta, M. A. K. Rumi, L. N. Kent, M. J. Soares, and S. Paul Context-dependent Function of Regulatory Elements and a Switch in Chromatin Occupancy between GATA3 and GATA2 Regulate Gata2 Transcription during Trophoblast Differentiation J. Biol. Chem., February 20, 2009; 284(8): 4978 - 4988. [Abstract] [Full Text] [PDF]

				M. Stumpf, C. Waskow, M. Krotschel, D. van Essen, P. Rodriguez, X. Zhang, B. Guyot, R. G. Roeder, and T. Borggrefe The mediator complex functions as a coactivator for GATA-1 in erythropoiesis via subunit Med1/TRAP220 PNAS, December 5, 2006; 103(49): 18504 - 18509. [Abstract] [Full Text] [PDF]

				D.R.H. de Bruijn, W.J.M. Peters, S.M. Chuva de Sousa Lopes, A.H.A. van Dijk, M.P. Willemse, R. Pfundt, P. de Boer, and A. Geurts van Kessel Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression Hum. Mol. Genet., October 1, 2006; 15(19): 2936 - 2944. [Abstract] [Full Text] [PDF]

				S. Flajollet, B. Lefebvre, C. Rachez, and P. Lefebvre Distinct Roles of the Steroid Receptor Coactivator 1 and of MED1 in Retinoid-induced Transcription and Cellular Differentiation J. Biol. Chem., July 21, 2006; 281(29): 20338 - 20348. [Abstract] [Full Text] [PDF]

				T. S. Udayakumar, M. Belakavadi, K.-H. Choi, P. K. Pandey, and J. D. Fondell Regulation of Aurora-A Kinase Gene Expression via GABP Recruitment of TRAP220/MED1 J. Biol. Chem., May 26, 2006; 281(21): 14691 - 14699. [Abstract] [Full Text] [PDF]

				D. F. Gordon, E. A. Tucker, K. Tundwal, H. Hall, W. M. Wood, and E. C. Ridgway MED220/Thyroid Receptor-Associated Protein 220 Functions as a Transcriptional Coactivator with Pit-1 and GATA-2 on the Thyrotropin-{beta} Promoter in Thyrotropes Mol. Endocrinol., May 1, 2006; 20(5): 1073 - 1089. [Abstract] [Full Text] [PDF]

				M. A. Mahajan and H. H. Samuels Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development Endocr. Rev., June 1, 2005; 26(4): 583 - 597. [Abstract] [Full Text] [PDF]

				J. M. R. Moore and R. K. Guy Coregulator Interactions with the Thyroid Hormone Receptor Mol. Cell. Proteomics, April 1, 2005; 4(4): 475 - 482. [Abstract] [Full Text] [PDF]

				I. Pineda Torra, L. P. Freedman, and M. J. Garabedian Identification of DRIP205 as a Coactivator for the Farnesoid X Receptor J. Biol. Chem., August 27, 2004; 279(35): 36184 - 36191. [Abstract] [Full Text] [PDF]

				Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, Y.-J. Zhu, M. S. Rao, D. Le Roith, P. Chambon, F. J. Gonzalez, and J. K. Reddy Transcription Coactivator PBP, the Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein, Is Required for PPAR{alpha}-regulated Gene Expression in Liver J. Biol. Chem., June 4, 2004; 279(23): 24427 - 24434. [Abstract] [Full Text] [PDF]

				J. K. Reddy Peroxisome Proliferators and Peroxisome Proliferator-Activated Receptor {alpha}: Biotic and Xenobiotic Sensing Am. J. Pathol., June 1, 2004; 164(6): 2305 - 2321. [Full Text] [PDF]